Publication:
Regional Success on Screening and Chemoprophylaxis in Contacts of Patients with Pulmonary Tuberculosis in Turkey: A Dispensary Experience in 2016-2017

dc.authorscopusid6603064151
dc.authorscopusid57209480402
dc.authorscopusid55279911600
dc.contributor.authorDundar, C.
dc.contributor.authorÖztomurcuk, D.
dc.contributor.authorTerzi, O.
dc.date.accessioned2020-06-21T12:26:42Z
dc.date.available2020-06-21T12:26:42Z
dc.date.issued2019
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Dundar] C., Department of Public Health, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Öztomurcuk] Derya, Samsun Tuberculosis Dispensary of Health Directorate, Samsun, Turkey; [Terzi] Özlem Zel, Department of Public Health, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBackground: Turkey has a national tuberculosis (TB) control program that follows the standards set by the World Health Organization's (WHO) global TB control program. Methods: In this record-based retrospective study, contact screening and chemoprophylaxis of 469 TB contacts registered at the Samsun Tuberculosis Dispensary in 2016-2017 were assessed. Results: On average, patients with pulmonary TB each had four contacts. Chemoprophylaxis was administered in 233 of the contacts for the following reasons: having close contact with an active TB patient (187 [80%]), being <15 y of age and tuberculin skin test (TST) positive (12 [5%]), detection of latent TB infection (27 [12%]) or not having been treated for TB before in conjunction with the discovery via radiography of a sequel lesion (7 [3%]). The remaining 236 contacts were not given chemoprophylaxis: 203 (86%) were TST negative, 10 (4%) rejected chemoprophylaxis and 23 (10%) refused to participate in an examination. Chemoprophylaxis was given to 30% of contacts in the first week and to 75% of contacts in the first month. The treatment completion rate was 80%, while the rate of chemoprophylaxis abandonment was 19.5% for males and 21.2% for females. Conclusions: The Samsun TB dispensary is successfully implementing the WHO's End TB strategy and has achieved higher treatment completion rates than other countries. © 2019 The Author(s).en_US
dc.identifier.doi10.1093/trstmh/trz008
dc.identifier.endpage355en_US
dc.identifier.issn0035-9203
dc.identifier.issn1878-3503
dc.identifier.issue6en_US
dc.identifier.pmid30892630
dc.identifier.scopus2-s2.0-85067907850
dc.identifier.scopusqualityQ2
dc.identifier.startpage351en_US
dc.identifier.urihttps://doi.org/10.1093/trstmh/trz008
dc.identifier.volume113en_US
dc.identifier.wosWOS:000474278400009
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofTransactions of the Royal Society of Tropical Medicine and Hygieneen_US
dc.relation.journalTransactions of the Royal Society of Tropical Medicine and Hygieneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChemoprophylaxisen_US
dc.subjectContact Screeningen_US
dc.subjectDispensaryen_US
dc.subjectTreatment Completionen_US
dc.subjectTuberculosisen_US
dc.titleRegional Success on Screening and Chemoprophylaxis in Contacts of Patients with Pulmonary Tuberculosis in Turkey: A Dispensary Experience in 2016-2017en_US
dc.typeArticleen_US
dspace.entity.typePublication

Files